Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
University Cancer Research Fund updates, record poster session highlights of 2011 scientific retreat
The sixth annual UNC Lineberger scientific retreat drew a record number of posters – 68 – for the poster session and competition – and close to 150 people for the talks and reception.
LIVESTRONG® Survivorship Center of Excellence Network to Host Landmark Meeting on Survivorship Care and Advocacy in Response to 2011 Report Findings
Conference will be held in Washington, D.C., Sept. 15-16. UNC Lineberger Comprehensive Cancer Center is part of a collaborative effort among leading medical institutions brought together by LIVESTRONG.
Dr. Stuart Gold is division chief of UNC Lineberger's pediatric hematology and oncology program.
2011 Statesman Award honors extraordinary voluntary efforts
UNC Lineberger’s Fellowship Program in Hematology/Oncology is being recognized by the American Society of Clinical Oncology (ASCO) this weekend at the organization’s annual meeting in Chicago, Illinois.
Each year, the President’s Cancer Panel assembles a group of experts to provide official testimony about the nation’s cancer agenda. The theme changes annually – for 2009-2010 the panel focused on “America’s Demographic and Cultural Transformation: Implications for Cancer.” A full report was released this spring.
Finding points new direction for study of chronic Hepatitis C
Input sought from Fayetteville’s African-American and Latino communities
CHAPEL HILL, N.C. - The article "Why do men die earlier?" written by Bridget Murray-Law and published in the June 2011 issue of Monitor on Psychology, looks at new research that analyzes how men take care of themselves.
Dr. Shelley Earp, UNC Lineberger Comprehensive Cancer Center director, joined Nick Valvano, CEO of The V Foundation for Cancer Research, on ABC 11’s Heart of Carolina Perspectives show which aired on Sunday, June 19, 2011.
New drugs should work for rare blood disorder
Gary Rosson was honored by the NC Triangle Komen Race for the Cure as the 2011 winner of the Co-Survivor Award. Rosson is a research associate in the lab of UNC Lineberger faculty member Scott Bultman.
Chapel Hill - UNC Lineberger Comprehensive Cancer Center honored three clinical oncology fellows with $5,000 awards for their research accomplishments and clinical excellence. These first-ever awards were given to Daniel Higginson, MD, Autumn McRee, MD, and Emma Rossi, MD.
Chapel Hill - The human immune system is a double-edged sword. While it is finely adapted to fighting potentially deadly viruses, such as the H1N1 influenza, the mechanisms it uses to fight pathogens can have negative effects such as inflammatory disorders or autoimmune diseases.
Recent UNC-Chapel Hill graduate and former UNC Women’s Basketball player Jessica Breland – who now plays in the WNBA for the New York Liberty – was honored with the the 23rd annual Honda Inspiration Award.
Chapel Hill - Thomas Shea, MD, will serve a two-year term as chair of the Scientific Advisory Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR). He was previously elected as chair-elect. The Advisory Committee establishes policy for, and provides scientific direction to the CIBMTR.
UNC completes miRNA and array analysis
American life expectancies, which have climbed steadily for almost a century, may drop in years to come as the obesity epidemic progresses.
Six new fellows have joined the Division of Hematology/Oncology.
Chapel Hill - Channing Der, PhD, Kenan Professor of Pharmacology, and Yue Xiong, PhD, Kenan Professor of Biochemistry and Biophysics, have been awarded the fourth annual Hyman L. Battle Distinguished Cancer Research Award in recognition of their accomplishments in cancer research. Both are members of UNC Lineberger Comprehensive Cancer Center.
Chapel Hill - A new fellowship training program in psychosomatic medicine is beginning at UNC, a partnership of the UNC School of Medicine Department of Psychiatry and the UNC Comprehensive Cancer Support Program, part of UNC Lineberger Comprehensive Cancer Center.
Chapel Hill, NC - Robert Adams, EdD, RT, CMD; Bahjat Qaqish, MD, PhD; and Jessica A. Church, BS, RT, all from UNC, and Kimberly L. MetCalf, EdD, RT, MR, from the Massachusetts General Hospital Institute of Health Professions are the winners of the 2010-2011 Jean I. Widger Distinguished Author Award from the American Society of Radiologic Technologists.
Using a patient’s genetic information can be successfully used to manage the drug concentrations of tamoxifen, a drug used to treat and prevent breast cancer.
Collaboration between University of North Carolina at Chapel Hill and Canadian scientists has resulted in a molecular probe capable of specifically targeting two proteins that affect a wide range of biological functions in humans by controlling the expression of certain genes.
CHAPEL HILL – For decades, scientists have known that DNA consists of four basic units – adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life. Yet in recent history, scientists have expanded that list from four to six.
Taking a look at telemedicine: program director talks about how it’s helping to fulfill UNC Lineberger’s mission
CHAPEL HILL, N.C. – The article "Telemedicine: Know why you're doing it " published online July 21, 2011 in Cardiovascular Business highlights the use of telemedicine at the N.C. Cancer Hospital.
Ken Jacobson, PhD, Kenan Professor of Cell and Developmental Biology in the UNC School of Medicine, received the Gregorio Weber Award for Excellence in Fluorescence Theory and Applications at the annual meeting of the Biophysical Society in Baltimore, Maryland.
The article "Oncologists by day, rock stars by night” written by Rachel Saslow and published in The Washington Post on July 25, 2011 features the band, N.E.D (which stands for “No Evidence of Disease”).
Male circumcision lowers prevalence of penile precancerous lesions among African men, UNC study finds
Chapel Hill - A University of North Carolina-led international study shows that among Kenyan men, circumcision is associated with a lower prevalence of human papillomavirus-associated precancerous lesions of the penis.
RALEIGH, NC – Crown Imports announced today that the highly successful “Corona Cares” charitable donation program in North Carolina will kick off on August 1 to benefit patients and families at the N.C. Cancer Hospital.
Project will assess needs and work to accelerate adoption of evidence-based cancer prevention interventions
Chapel Hill, NC – Lisa A. Carey, MD, Professor of Medicine, Medical Director of the UNC Breast Center and Associate Director for Clinical Research at UNC Lineberger Comprehensive Cancer Center has been appointed The Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research.
Discovery may have implications for many diseases
Marci Campbell, PhD, MPH, RD, authored a guest editorial titled "Cancer is a Team Sport" for the August 2011 issue of the Clinical Journal of Oncology Nursing.
Angelique Whitehurst, PhD, and her Stand Up to Cancer research grant were featured in an article in the August 2011 issue of Nature Medicine.
Karyn Stitzenberg, MD, MPH, is quoted in an article titled "Tracking the Rise of Robotic Surgery for Prostate Cancer" published in the August 9, 2011 issue of the NCI Cancer Bulletin.
National effort will shape the future of cancer research and treatment
Six new residents have begun their training with the UNC Department of Radiation Oncology.
Stephan Moll, MD, is quoted in an article titled "Blood Clots Pose Threat to All of Us," published today on Fox Business' website.
Cancer is a leading cause of widowed fatherhood in the United States. Faculty with UNC Lineberger Comprehensive Cancer Center’s Comprehensive Cancer Support Program authored a commentary titled “Single Fatherhood Due to Cancer” in the August issue of the journal Psycho-Oncology outlining challenges these fathers face and future directions to develop supportive interventions for them and their children.
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, talks with Kristy Villa, one of the hosts of Lifetime Television’s “The Balancing Act" about colon cancer.
Technology used to promote better health and cancer prevention statewide
Chapel Hill - University of North Carolina at Chapel Hill researcher Joseph DeSimone, PhD, will partner with scientists at two universities and a local biotechnology company to develop a nanoparticle vaccine for prostate cancer. The Prostate Cancer Foundation awarded the UNC-Beth Israel Deaconess Medical Center/Harvard-Johns Hopkins-Liquidia Technologies consortium a Challenge Award of $1 million, one of ten such awards funded by the organization.
New television ads for UNC Cancer Care are now airing. As we launch the UNC Cancer Care brand, we hope these ads reflect a little bit of what our outstanding clinical care programs are all about. Be sure to look for them on television! The ads can also be viewed below.
CHAPEL HILL, NC – In a kind of molecular gymnastics, scientists at the University of North Carolina at Chapel Hill School of Medicine have devised a gene therapy cocktail that has the potential to treat some inherited diseases associated with “misfolded” proteins.
Charles Perou, PhD, appointed May Goldman Shaw Distinguished Professorship of Molecular Oncology Research
Chapel Hill, NC – Charles M. Perou, PhD, professor of genetics, and pathology & laboratory medicine, and leader of the UNC Lineberger Comprehensive Cancer Center breast cancer research program has been appointed the May Goldman Shaw Distinguished Professor of Molecular Oncology Research. The professorship, established by a $1 million gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas is named in honor of Mrs. Lowenbaum’s mother, May Goldman Shaw.
An expert interview with Laura Linnan, ScD, CHES, is featured in News & Views, a publication of the Wellness Council of America (WELCOA).
Each month the Patient Resource Cancer Guide recognizes an oncology nurse who exhibits dedication and compassion for his/her patients and profession - Delma Armstrong, BSN, RN, OCN, is the featured oncology nurse for June 2011.
Proteins made by cancer cells focus of effort
A grant from The V Foundation for Cancer Research is helping to fund skin cancer research at UNC Lineberger.
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, is quoted in the Health section of USA Today's website.
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
CHAPEL HILL, N.C. It takes life-saving research to Conquer Kids’ Cancer! The St. Baldrick’s Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, has awarded a $330,000 St. Baldrick’s Scholar award to Timothy Gershon, MD, PhD, and assistant professor of neurology at the School of Medicine at the University of North Carolina at Chapel Hill.
The UNC Comprehensive Cancer Support Program is sponsoring a monthly community educational series called “Cancer Conversations.” Featuring UNC physicians and others, the series is a time intended to help people learn from and talk with cancer experts. The sessions will be held the third Tuesday of each month from 7:00 – 8:30 pm: September 20, October 18, November 15 (no session in December).
Close to 40 participants braved Hurricane Irene to learn how to be effective advocates for lung cancer.
Men who are 40 years old or older, or who have a family history of prostate cancer, may make an appointment in advance by calling 919-966-1316. Walk-ins are also accepted.
Causes of African-American breast cancer incidence study receives $19.3M: UNC partners to form largest US database
Chapel Hill - UNC scientist Robert Millikan will partner with Christine Ambrosone, of Roswell Park Cancer Institute, and Julie R. Palmer, of Boston University, in the most ambitious study to date of breast cancer among younger African-American women.
Hyundai Hope on Wheels and Raleigh-Durham Area Hyundai Dealers today awarded Ian Davis, MD, PhD, a $100,000 grant to support research into the causes of and treatments for pediatric sarcoma. Davis, assistant professor of pediatrics and genetics and a member of UNC Lineberger Comprehensive Cancer Center is one of 71 recipients of Hyundai Hope on Wheels’ 2011 Hope Grant program, where $7.1 million will be awarded to support research and programs in honor of National Childhood Cancer Awareness Month.
Susan McKenney, APRN, BC, MSN, OCN, Clinical Associate Professor of Surgery, has been selected by NBC 17, along with Chapel Hill and Durham magazines, as a Super 17 Nurse.
Wizdom Powell Hammond, PhD, assistant professor of health behavior and health education at UNC Gillings School of Global Public Health, has been named to the 2011-2012 class of White House Fellows, the White House recently announced.
Chapel Hill, NC – Stefanie Sarantopoulos, MD, PhD, was recruited to UNC in 2009 with the help of the University Cancer Research Fund. Now she is a recipient of two grants that have helped establish her own laboratory to look into the causes of chronic Graft vs. Host Disease. Sarantopoulos is an Assistant Professor of Medicine in the Division of Hematology/Oncology and Microbiology and Immunology and a member of UNC Lineberger Comprehensive Cancer Center.
Chapel Hill, NC – Lawrence B. Marks, MD, chairman of the UNC Department of Radiation Oncology, has been appointed the Dr. Sidney K. Simon Distinguished Professor of Oncology Research at UNC-Chapel Hill. The professorship, established by a $500K gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas, is named in honor of Mr. Loewenbaum’s grandfather, Dr. Sidney K. Simon.
Chapel Hill - Deciding whether or not to have breast reconstruction after mastectomy is highly challenging for many patients. Clara Lee, MD, MPP, a UNC School of Medicine physician/scientist, has received a five-year grant award to examine patients’ decision-making process about reconstruction and the effects of reconstruction on quality of life and body image. The $862,700.00 career development award to the plastic and reconstructive surgeon is from the National Institutes of Health.
Two UNC Lineberger faculty, Noel Brewer, PhD, associate professor of health behavior and health education in the UNC Gillings School of Global Public Health, and Karen Mohlke, PhD, associate professor of genetics in the UNC School of Medicine, have received the 2011 Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty at UNC-Chapel Hill.
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.
Kevin Weeks, a chemist at the University of North Carolina at Chapel Hill, has received an award from the National Institutes of Health to support innovative research on creating new drugs that work by binding to RNA.
Two recent grants from the National Science Foundation will support soft matter research at the University of North Carolina at Chapel Hill.
CHAPEL HILL – A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person’s risk of schizophrenia and bipolar disorder.
CHAPEL HILL – Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body’s own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.
Seventh annual event benefits cancer research and treatment in our community
CHAPEL HILL – When sperm meets egg, the chemical instructions that tag sperm cells must be erased so that human life can start anew. One way these instructions are erased is through demethylation, the removal of specific chemical tags or methyl groups that dot the underlying DNA of cells. Though scientists have known about this phenomenon for a decade, exactly how such “reprogramming” occurs has proved elusive.
Chapel Hill - A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor of Chemistry and Pharmacy, and colleagues report their finding online in advance of print on September 14, 2011 in Angewandte Chemie, the German-based flagship chemistry journal.
CHAPEL HILL, N.C. – Weili Lin, PhD, professor of radiology, neurology and biomedical engineering and director of the UNC Biomedical Research Imaging Center, has been appointed The Dixie Lee Boney Soo Distinguished Professor in Neurological Medicine.
Chapel Hill - A team of UNC scientists report that in laboratory studies, overexpression of a specific protein could be used as a prognostic marker and as a guide for therapeutic choices for patients with head and neck cancer. Their findings appear in the September 9, 2011 online issue of the journal Clinical Cancer Research.
Toolkit moves best practices to the community
Chapel Hill, NC – G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Keith Amos, MD, quoted in The Huffington Post
Noel Brewer, a professor of public health at UNC who has also studied HPV vaccine use, said the public controversy has been less harmful than the fact that many doctors simply don’t know or choose not to recommend it, or that many parents have insurance plans that don’t cover the vaccine or charge large co-pays for it.
CHAPEL HILL, N.C. - Patients who have high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study. Their study is the first to report on multiple patients with these skin carcinomas treated simultaneously with radio-and chemotherapy.
Jian Jin, PhD, an associate professor and director of medicinal chemistry in the Center for Integrative Chemical Biology and Drug Discovery at UNC-Chapel Hill, is featured in endeavors magazine.
Channing Der and his wife, Kathy, had already planned a 30th wedding anniversary trip to Kenya. After hearing Carolina alumnus and author Rye Barcott talk about his book, It Happened on the Way to War: A Marine’s Path to Peace, and describe the Carolina for Kibera program in Nairobi, Kenya, they knew they had to see the program in action.
Dr. Nicholas Shaheen, professor in the UNC School of Medicine, adjunct professor in the UNC Gillings School of Global Public Health and director of the UNC Center for Esophageal Diseases and Swallowing, will co-direct Barrett’s Esophagus Translational Research Network (BETRNet) projects.
Grant from the Centers for Disease Control focuses on younger breast cancer patients
UNC scientists report that in early stage, asymptomatic non-small cell lung cancer, early brain recurrences are potentially detectable prior to surgery and recommend that physicians consider including a routine pre-operative staging brain MRI. In addition, patients whose tumors are determined to be higher risk based on the findings at surgery, should consider post-operative MRI to offer early treatment of unrecognized metastasis.
CHAPEL HILL – The governance committee of the University Cancer Research Fund has established first-year spending priorities for the state’s initial $25 million investment at the University of North Carolina at Chapel Hill.
Stephen Frye, PhD, former worldwide head of discovery medicinal chemistry at GlaxoSmithKline, will lead the new Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill.
Winston-Salem Journal Editorial, August 8, 2007
Editorials, Charlotte Observer, August 3, 2007
Funding will improve quality of life for cancer patients, families statewide
CHAPEL HILL - The University of North Carolina’s two medical schools and their cancer centers have signed a memorandum of understanding that creates a partnership to advance cancer research and bring leading-edge treatment to North Carolinians.
CHAPEL HILL - Fred Eshelman, chief executive officer and founder of Wilmington-based PPD Inc., has pledged $9 million to support cancer research at the School of Pharmacy at the University of North Carolina at Chapel Hill.
University Cancer Research Fund Grant Teams Lineberger Faculty with Renaissance Computing Institute to Battle Skin Cancer
CHAPEL HILL, NC - A new collaboration between melanoma researchers in the School of Medicine at the University of North Carolina at Chapel Hill, the Renaissance Computing Institute (RENCI), and researchers from the departments of computer science, epidemiology, biostatistics, and statistics and operations research at UNC Chapel Hill aims to use image analysis techniques to aid doctors in the fight against melanoma, the most serious form of skin cancer.
On June 20, Dr. Lisa Carey, medical director of the UNC Breast Center, gave a talk on “Everything You Always Wanted to Know about Breast Cancer But Were Afraid to Ask” in Dare County. This inaugural “Lunch & Learn” was held in the Cancer Resource Center of the Outer Banks Hospital with an at-capacity crowd of 40 people.
On Friday, June 6th, the UNC Specialty Clinic opened its doors to patients in Dare County and the surrounding areas. Dr. Thomas Shea, UNC Lineberger Comprehensive Cancer Center associate director of clinical outreach, and Jean Sellers, RN, oncology program manager traveled to Nag’s Head for the first day of clinic operations.
Carol Shores, MD, PhD, FACS, has been interested in the link between viruses and cancer for over 20 years, after working on virus- associated cancers as a pre-doctoral fellow in the UNC Department of Biochemistry and Biophysics. Oropharyngeal cancers, like cervical cancer, are associated with human papilloma viruses and endemic Burkitt lymphoma, a childhood cancer in sub-Saharan Africa, is associated with Epstein-Barr virus.
UNC-Chapel Hill Chancellor Emeritus James Moeser talks with Shelley Earp, MD, director of the UNC Lineberger Comprehensive Cancer Center, about the creation and development of the cancer center. This discussion is the third in a series based on the book "Good to Great" by Jim Collins.
Terry Magnuson, PhD, Sarah Graham Kenan Professor, Chair of the Department of Genetics, and Vice Dean for Research at the School of Medicine, is featured in a spotlight story on UNC-Chapel Hill's website.